Revance Therapeutics, Inc. (RVNC) Social Stream
REVANCE THERAPEUTICS INC (RVNC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RVNC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 9 | $55 | $17 | $31.222 | $7.03 | 344.13% |
| 2021-11-11 | 9 | $55 | $17 | $30.888 | $7.03 | 339.37% |
| 2022-02-28 | 9 | $55 | $17 | $28.111 | $7.03 | 299.87% |
| 2022-05-24 | 9 | $55 | $17 | $28.333 | $7.03 | 303.03% |
| 2022-08-09 | 8 | $55 | $17 | $28.333 | $7.03 | 303.03% |
| 2022-08-11 | 8 | $55 | $17 | $28.888 | $7.03 | 310.92% |
| 2022-08-25 | 8 | $55 | $22 | $29.666 | $7.03 | 321.99% |
| 2022-09-09 | 10 | $65 | $24 | $34.222 | $7.03 | 386.8% |
| 2022-09-28 | 10 | $65 | $24 | $34.1 | $7.03 | 385.06% |
| 2022-10-11 | 10 | $65 | $24 | $33.454 | $7.03 | 375.87% |
| 2022-11-09 | 11 | $65 | $24 | $33.454 | $7.03 | 375.87% |
| 2022-12-06 | 11 | $65 | $24 | $33.636 | $7.03 | 378.46% |
| 2023-01-10 | 11 | $65 | $24 | $33.909 | $7.03 | 382.35% |
| 2023-01-23 | 11 | $65 | $24 | $34 | $7.03 | 383.64% |
| 2023-01-26 | 11 | $65 | $24 | $35.182 | $7.03 | 400.46% |
| 2023-01-31 | 11 | $65 | $24 | $36.182 | $7.03 | 414.68% |
| 2023-03-01 | 10 | $65 | $24 | $37.555 | $7.03 | 434.21% |
| 2023-03-15 | 10 | $65 | $24 | $38.222 | $7.03 | 443.7% |
| 2023-04-10 | 10 | $65 | $26 | $38.3 | $7.03 | 444.81% |
| 2023-04-19 | 11 | $42 | $26 | $35.333 | $7.03 | 402.6% |
| 2023-05-10 | 11 | $65.001 | $26 | $38.3 | $7.03 | 444.81% |
| 2023-05-11 | 11 | $65 | $26 | $40.4 | $7.03 | 474.68% |
| 2023-08-08 | 11 | $65 | $26 | $40.6 | $7.03 | 477.52% |
| 2023-08-09 | 11 | $65 | $25 | $39.4 | $7.03 | 460.46% |
| 2023-08-16 | 11 | $65 | $20 | $37.9 | $7.03 | 439.12% |
| 2023-09-21 | 10 | $65 | $20 | $37.222 | $7.03 | 429.47% |
| 2023-10-11 | 10 | $65 | $12 | $35.5 | $7.03 | 404.98% |
| 2023-10-23 | 10 | $65 | $12 | $35 | $7.03 | 397.87% |
| 2023-11-09 | 10 | $65 | $12 | $32.4 | $7.03 | 360.88% |
| 2023-11-10 | 10 | $42 | $12 | $28.4 | $7.03 | 303.98% |
| 2023-11-24 | 11 | $42 | $12 | $27.272 | $7.03 | 287.94% |
The Trend in the Analyst Price Target
RVNC's average price target has moved down $10.53 over the prior 32 months.
RVNC reports an average of 111.42% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 11 | 65 | 26 | 38.300 | 31.47 | 21.7% |
| 2023-05-11 | 11 | 65 | 26 | 40.400 | 35.72 | 13.1% |
| 2023-07-12 | 11 | 65 | 26 | 40.600 | 23.35 | 73.88% |
| 2023-07-27 | 11 | 65 | 26 | 40.600 | 22.02 | 84.38% |
| 2023-09-21 | 10 | 65 | 20 | 37.222 | 12.47 | 198.49% |
RVNC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.45 | 8 | 1 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 42 months, RVNC's average broker recommendation rating worsened by 0.17.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, REVANCE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3426.97% of them.
- In terms of how REVANCE THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3264.27% of that group.
- RVNC has a greater number of analysts covering the stock than 2677.8% of stocks in the mid market cap category.
- RVNC has a greater average analyst price target than 2105.22% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, TBPH, PRTA, and AGIO are the three stocks most similar to REVANCE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for RVNC? Use POWR Ratings for clearer insight into price direction.